Booking platforms
Intranet
fr
en
Menu
Close
Booking platforms
Intranet
fr
en
The institute
Pages
Directory
About C3M…
The research
Pages
The research teams
The publications
The patents
the platforms
Pages
Cytometry
Histology
Genomics
Metabolism
Shared services
Events
Jobs
Home page
Publications PubMed
A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.
The Journal of investigative dermatology
May 2014
Description
Research
0
result(s)
